HT
ANIP icon

Headlands Technologies’s ANI Pharmaceuticals ANIP Stock Holding History

Headlands Technologies’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$756K Buy
9,830
+446
+5% +$34.8K 0.09% 274
2025
Q4 		$741K Buy
9,384
+2,388
+34% +$207K 0.06% 320
2025
Q3 		$641K Buy
6,996
+3,258
+87% +$266K 0.05% 310
2025
Q2 		$244K Sell
3,738
-1,631
-30% -$106K 0.03% 436
2025
Q1 		$359K Buy
5,369
+4,171
+348% +$249K 0.04% 344
2024
Q4 		$66.2K Sell
1,198
-7,091
-86% -$407K 0.01% 758
2024
Q3 		$495K Buy
+8,289
New +$506K 0.06% 345
2024
Q2 		– Sell
-194
Closed -$13.4K – 1133
2024
Q1 		$13.4K Buy
+194
New +$11.7K ﹤0.01% 989

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return